VHL disease is characterized by mutations in VHL gene on chromosome 3, mutations that are found in 90% of ccRCC and lead to a decrease of gene products and an increased expression of HIF-1,2 [44]. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.